# Vascular Biogenics Ltd. (VBLT)

Source: https://www.quantisnow.com/company/VBLT
Generated: 2026-11-18T06:56:34.138Z

- Ticker: VBLT
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2014
- Website: vblrx.com

## About

Vascular Biogenics Ltd., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for cancer and immune/inflammatory indications. The company's program is based on its proprietary vascular targeting system platform technology, which utilizes genetically targeted therapy to destroy newly formed or angiogenic blood vessels. Its lead product candidate is VB-111, a gene-based biologic that is in Phase III clinical trials for the recurrent platinum-resistant ovarian cancer; and Phase II clinical trials treatment of recurrent glioblastoma and colorectal cancer, as well as has completed Phase II clinical trial for the treatment of thyroid cancer. It is also developing VB-511, an anti-angiogenic candidate for oncology; VB-211 and VB-411, which are pro-angiogenic candidates for the treatment of peripheral vascular diseases; and VB-703 for NASH and renal fibrosis. In addition, the company is developing VB-201, a Lecinoxoid-based product candidate to treat atherosclerosis that has completed Phase II clinical; and is in Phase II exploratory trials for COVID-19, as well as in pre-clinical stage for the treatment of NASH and renal fibrosis. It is also developing VB-601 for various inflammatory indications, and VB-611 for various solid tumors. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.

## Latest VBLT news and filings

- 2024-02-16 14:00 UTC [SEC Form DEF 14A] [SEC Form DEF 14A filed by Vascular Biogenics Ltd.](https://www.quantisnow.com/insight/sec-form-def-14a-filed-by-vascular-biogenics-ltd-5269908)
- 2024-02-05 22:00 UTC [SEC Form PRE 14A] [SEC Form PRE 14A filed by Vascular Biogenics Ltd.](https://www.quantisnow.com/insight/sec-form-pre-14a-filed-by-vascular-biogenics-ltd-5230711)
- 2024-02-02 21:05 UTC [SEC Form 8-K] [Vascular Biogenics Ltd. filed SEC Form 8-K: Financial Statements and Exhibits](https://www.quantisnow.com/insight/vascular-biogenics-ltd-filed-sec-form-8-k-financial-statements-and-5226543)
- 2024-01-26 16:05 UTC [SEC Form 4] [SEC Form 4 filed by Feinberg Peter](https://www.quantisnow.com/insight/sec-form-4-filed-by-feinberg-peter-5210250)
- 2024-01-26 16:05 UTC [SEC Form 4] [SEC Form 4 filed by Patsi Tuomo](https://www.quantisnow.com/insight/sec-form-4-filed-by-patsi-tuomo-5210248)
- 2024-01-26 16:04 UTC [SEC Form 4] [SEC Form 4 filed by Galen Michele](https://www.quantisnow.com/insight/sec-form-4-filed-by-galen-michele-5210247)
- 2024-01-26 16:04 UTC [SEC Form 4] [SEC Form 4 filed by Graney Thomas](https://www.quantisnow.com/insight/sec-form-4-filed-by-graney-thomas-5210246)
- 2024-01-26 16:02 UTC [SEC Form 4] [SEC Form 4 filed by Dubin Thomas I H](https://www.quantisnow.com/insight/sec-form-4-filed-by-dubin-thomas-i-h-5210243)
- 2024-01-26 16:02 UTC [SEC Form 4] [SEC Form 4 filed by Rice Yehuda Michael](https://www.quantisnow.com/insight/sec-form-4-filed-by-rice-yehuda-michael-5210241)
- 2024-01-11 22:22 UTC [SEC Schedule 13G] [SEC Form SC 13G/A filed by Vascular Biogenics Ltd. (Amendment)](https://www.quantisnow.com/insight/sec-form-sc-13ga-filed-by-vascular-biogenics-ltd-amendment-5184604)
- 2024-01-08 21:21 UTC [SEC Form RW filed by Vascular Biogenics Ltd.](https://www.quantisnow.com/insight/sec-form-rw-filed-by-vascular-biogenics-ltd-5176692)
- 2024-01-03 22:00 UTC [SEC Form 4] [Fr Capital Holdings, L.P. sold $94,670 worth of Ordinary Shares (50,000 units at $1.89) (SEC Form 4)](https://www.quantisnow.com/insight/fr-capital-holdings-lp-sold-94670-worth-of-ordinary-shares-5166017)
- 2024-01-02 22:00 UTC [SEC Form 4] [Fr Capital Holdings, L.P. sold $54,136 worth of Ordinary Shares (27,500 units at $1.97) (SEC Form 4)](https://www.quantisnow.com/insight/fr-capital-holdings-lp-sold-54136-worth-of-ordinary-shares-5161943)
- 2023-12-28 22:00 UTC [SEC Form 4] [Fr Capital Holdings, L.P. sold $66,460 worth of Ordinary Shares (31,489 units at $2.11) (SEC Form 4)](https://www.quantisnow.com/insight/fr-capital-holdings-lp-sold-66460-worth-of-ordinary-shares-5157858)
- 2023-12-26 22:00 UTC [SEC Form 4] [Fr Capital Holdings, L.P. sold $115,475 worth of Ordinary Shares (47,867 units at $2.41) (SEC Form 4)](https://www.quantisnow.com/insight/fr-capital-holdings-lp-sold-115475-worth-of-ordinary-shares-5155152)
- 2023-12-18 13:15 UTC [SEC Form 8-K] [SEC Form 8-K filed by Vascular Biogenics Ltd.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-vascular-biogenics-ltd-5142340)
- 2023-11-29 22:15 UTC [SEC Form 8-K] [Vascular Biogenics Ltd. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/vascular-biogenics-ltd-filed-sec-form-8-k-financial-statements-and-5109525)
- 2023-11-29 22:00 UTC [SEC Form 8-K] [Vascular Biogenics Ltd. filed SEC Form 8-K: Financial Statements and Exhibits (Amendment)](https://www.quantisnow.com/insight/vascular-biogenics-ltd-filed-sec-form-8-k-financial-statements-and-5109455)
- 2023-10-20 13:00 UTC [SEC Form 8-K] [Vascular Biogenics Ltd. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/vascular-biogenics-ltd-filed-sec-form-8-k-other-events-5030054)
- 2023-10-19 17:34 UTC [SEC Schedule 13D] [SEC Form SC 13D filed by Vascular Biogenics Ltd.](https://www.quantisnow.com/insight/sec-form-sc-13d-filed-by-vascular-biogenics-ltd-5028650)
- 2023-10-19 17:31 UTC [SEC Form 3] [New insider Kim James Jimin claimed ownership of 2,284,610 units of Ordinary shares (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-kim-james-jimin-claimed-ownership-of-2284610-units-5028647)
- 2023-10-18 12:40 UTC [SEC Form 3] [New insider Dubin Thomas I H claimed no ownership of stock in the company (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-dubin-thomas-i-h-claimed-no-ownership-of-5025715)
- 2023-10-18 12:37 UTC [SEC Form 3] [New insider Bock Thomas claimed no ownership of stock in the company (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-bock-thomas-claimed-no-ownership-of-stock-in-5025712)
- 2023-10-18 12:36 UTC [SEC Form 3] [New insider Patsi Tuomo claimed no ownership of stock in the company (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-patsi-tuomo-claimed-no-ownership-of-stock-in-5025709)
- 2023-10-18 12:36 UTC [SEC Form 3] [New insider Wagner Joseph P claimed no ownership of stock in the company (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-wagner-joseph-p-claimed-no-ownership-of-stock-5025706)
- 2023-10-18 12:36 UTC [SEC Form 3] [New insider Galen Michele claimed no ownership of stock in the company (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-galen-michele-claimed-no-ownership-of-stock-in-5025705)
- 2023-10-18 12:35 UTC [SEC Form 3] [New insider Feinberg Peter claimed no ownership of stock in the company (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-feinberg-peter-claimed-no-ownership-of-stock-in-5025703)
- 2023-10-18 12:35 UTC [SEC Form 3] [New insider Mcpherson Scott Alan claimed no ownership of stock in the company (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-mcpherson-scott-alan-claimed-no-ownership-of-stock-5025700)
- 2023-10-18 12:27 UTC [SEC Form 3] [New insider Graney Thomas claimed no ownership of stock in the company (SEC Form 3)](https://www.quantisnow.com/insight/new-insider-graney-thomas-claimed-no-ownership-of-stock-in-5025643)
- 2023-10-17 21:01 UTC [SEC Form S-3] [SEC Form S-3 filed by Vascular Biogenics Ltd.](https://www.quantisnow.com/insight/sec-form-s-3-filed-by-vascular-biogenics-ltd-5024731)
- 2023-10-17 12:00 UTC [SEC Form 8-K] [SEC Form 8-K filed by Vascular Biogenics Ltd.](https://www.quantisnow.com/insight/sec-form-8-k-filed-by-vascular-biogenics-ltd-5023063)
- 2023-10-16 20:05 UTC [SEC Form 8-K] [Vascular Biogenics Ltd. filed SEC Form 8-K: Completion of Acquisition or Disposition of Assets, Leadership Update, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vascular-biogenics-ltd-filed-sec-form-8-k-completion-of-acquisition-5021940)
- 2023-10-16 17:01 UTC [Earnings Date] [Notable Labs Closes Merger Transaction With VBL Therapeutics](https://www.quantisnow.com/insight/notable-labs-closes-merger-transaction-with-vbl-therapeutics-5021612)
- 2023-10-12 20:26 UTC [SEC Form 8-K] [Vascular Biogenics Ltd. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits](https://www.quantisnow.com/insight/vascular-biogenics-ltd-filed-sec-form-8-k-submission-of-matters-5017872)
- 2023-10-12 13:00 UTC [VBL Therapeutics Announces Results of Annual and Special Shareholder Meeting](https://www.quantisnow.com/insight/vbl-therapeutics-announces-results-of-annual-and-special-shareholder-meeting-5016720)
- 2023-10-10 12:19 UTC [Market Insight] [Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-immunic-shares-are-trading-higher-by-around-13-here-5011698)
- 2023-10-10 12:01 UTC [SEC Form 425] [SEC Form 425 filed by Vascular Biogenics Ltd.](https://www.quantisnow.com/insight/sec-form-425-filed-by-vascular-biogenics-ltd-5011630)
- 2023-10-10 12:00 UTC [SEC Form 8-K] [Vascular Biogenics Ltd. filed SEC Form 8-K: Other Events](https://www.quantisnow.com/insight/vascular-biogenics-ltd-filed-sec-form-8-k-other-events-5011614)
- 2023-10-09 12:20 UTC [Market Insight] [Why Avidity Biosciences Shares Are Trading Higher By Around 9%: 20 Stocks Moving Premarket](https://www.quantisnow.com/insight/why-avidity-biosciences-shares-are-trading-higher-by-around-9-5010269)
- 2023-10-04 20:33 UTC [SEC Form 425] [SEC Form 425 filed by Vascular Biogenics Ltd.](https://www.quantisnow.com/insight/sec-form-425-filed-by-vascular-biogenics-ltd-5004864)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/VBLT
- Earnings history: https://www.quantisnow.com/earnings/VBLT
- Dividend history: https://www.quantisnow.com/dividends/VBLT
- Insider transactions: https://www.quantisnow.com/insiders/VBLT
- Options chain: https://www.quantisnow.com/options/VBLT
- SEC 8-K filings only: https://www.quantisnow.com/company/VBLT/8-k
- RSS and alerts for VBLT: https://www.quantisnow.com/docs/rss-feeds.md
